This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page

Life Sciences Finance Transformation

Improving the health of today’s finance organizations in Life Sciences

Life sciences organizations face the challenge of converting great discoveries and research breakthroughs into public acceptance and market success. For companies specializing in pharmaceuticals, biotechnology, medical products and technology and medical devices, the pressure to grow, adapt and innovate in the face of increasing regulations and heightened expectations is simply status quo. As a result, life sciences chief financial officers (CFOs) and finance organizations are expected to execute on a much broader range of responsibilities beyond traditional accounting – including those related to finance function effectiveness, information quality and consistency, finance talent management, internal controls and corporate governance, business performance management and others. Click here to learn more about Life Sciences Finance Transformation services

Learn more about Life Sciences Finance Transformation by clicking on the tabs below:
  • Here's the debate
  • My take
  • Join the conversation

Featured insights

Life Sciences: Accounting and financial reporting update
This publication highlights specialized accounting and reporting considerations applicable to companies in this industry.
Life Sciences and Health Reform: No going back
Tune into the latest episode of Deloitte Insights to learn more about the impact of health care reform on the life sciences industry.
Deloitte’s 2013 global shared services survey results  
The report highlights that Shared Services is a mature concept, the next generation includes higher value processes, new geographies, and a higher utilization of hybrid models.
New video: 2013 Healthcare outlook
What’s around the corner for health care organizations and policymakers in 2013? Deloitte’s industry leaders discuss the coming year’s top issues and trends.
Our offerings

Finance Strategy and Vision 

  • Finance Strategy
  • Finance Operating Model Strategy
  • Finance Governance Strategy
  • Financial Risk Strategy
  • Finance Cost Reduction
  • Finance & Accounting Outsourcing Advisory
  • Finance Post Merger Integration
  • Finance Divestiture/Carve-out
  • Finance Restructuring
  • Finance Information Strategy
  • Shareholder Value & Performance Metric Advisory

 

Finance Organization 

  • Finance Organization Design
  • Finance Shared Services Design & Implementation
  • Finance Organization Risk & Controls
  • Finance Talent Management
  • Finance Training

 

Finance Systems 

  • Finance Information
  • Financial Systems
  • Tax Systems
  • Performance Management Systems
  • Risk & Compliance Systems
  • Finance Systems Risk & Controls
    Treasury Systems

Finance Processes

  • Financial Close & Consolidation
  • Order to Cash
  • Procure to Pay
  • Planning, Budgeting & Forecasting
  • External Reporting
  • Management Reporting
  • Cost & Profitability Analysis
  • Finance Benchmarking
  • Tax Accounting & Disclosure
  • Tax Compliance & Controversy
  • Tax Planning
  • Fixed Asset
  • Finance Process Risk & Controls
  • Accounting Policy & Procedures
  • Treasury Risk Management
  • Cash Management
  • Internal Audit
  • Fraud Assessment & Migration
  • Investor Relations

Finance Transformation Solution Sets

Case studies

Thinking outside the box: Learn how a pharmaceutical company transforms financial decision support services to improve performance and reduce costs
Finance Transformation in Pharmaceuticals: Learn how we helped a large pharmaceutical company to increased its focus on efficiency and costs.
Finance Transformation in Pharmaceuticals - From the F Troop to the 82nd Airborne: Learn how the finance organization at a leading pharmaceutical company generated considerable business value through its understanding of company issues, its analytical capabilities.

   

Deloitte’s Life Sciences Finance Transformation leadership team

Brad Smith
Principal, Life Sciences Finance Practice Lead, Deloitte Consulting LLP

Deloitte's Life Sciences Finance Transformation Advisory team

Steven Ehrenhalt
Principal, Global Leader, Finance Transformation Practice, Deloitte Consulting LLP
David Hodgson
Partner, Global Leader, Enterprise Risk Services, Deloitte & Touche LLP
Tom Hogan
Partner, Global Tax Leader, Life Sciences and Healthcare, Deloitte & Touche LLP
Sam Silvers
Principal, Northeast Regional Managing Partner, Deloitte Consulting LLP
Faisal Shaikh
Principal, Life Sciences Restructuring Lead, Deloitte Consulting LLP
Marc Kaplan
Principal, Human Capital, Deloitte Consulting LLP
Mike Delone
Principal, Technology, Deloitte Consulting LLP
Marty DiMarzio
Principal, Human Capital, Deloitte Consulting LLP
William Thomas
Principal, Technology, Deloitte Consulting LLP

As used in this document, "Deloitte" means Deloitte Consulting LLP, a subsidiary of Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.

Related links

Share this page

Email this Send to LinkedIn Send to Facebook Tweet this More sharing options

Stay connected